Annual Cash & Cash Equivalents
$80.14 M
-$14.72 M-15.52%
31 December 2023
Summary:
Molecular Partners AG annual cash & cash equivalents is currently $80.14 million, with the most recent change of -$14.72 million (-15.52%) on 31 December 2023. During the last 3 years, it has fallen by -$72.92 million (-47.64%). MOLN annual cash & cash equivalents is now -59.46% below its all-time high of $197.66 million, reached on 31 December 2015.MOLN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$78.16 M
+$5.09 M+6.96%
01 September 2024
Summary:
Molecular Partners AG quarterly cash and cash equivalents is currently $78.16 million, with the most recent change of +$5.09 million (+6.96%) on 01 September 2024. Over the past year, it has increased by +$3.40 million (+4.55%). MOLN quarterly cash and cash equivalents is now -60.46% below its all-time high of $197.66 million, reached on 31 December 2015.MOLN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOLN Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.5% | +4.5% |
| 3 y3 years | -47.6% | -11.9% |
| 5 y5 years | -20.3% | +12.9% |
MOLN Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.6% | +2.0% | -49.2% | +11.1% |
| 5 y | 5 years | -47.6% | +2.5% | -49.2% | +57.1% |
| alltime | all time | -59.5% | +2.5% | -60.5% | +57.1% |
Molecular Partners AG Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $78.16 M(+7.0%) |
| June 2024 | - | $73.07 M(-3.5%) |
| Mar 2024 | - | $75.75 M(-5.5%) |
| Dec 2023 | $80.14 M(-15.5%) | $80.14 M(+7.2%) |
| Sept 2023 | - | $74.76 M(+6.3%) |
| June 2023 | - | $70.33 M(-13.1%) |
| Mar 2023 | - | $80.93 M(-14.7%) |
| Dec 2022 | $94.86 M(+20.7%) | $94.86 M(+32.7%) |
| Sept 2022 | - | $71.48 M(-40.7%) |
| June 2022 | - | $120.44 M(-21.7%) |
| Mar 2022 | - | $153.82 M(+95.8%) |
| Dec 2021 | $78.56 M(-48.7%) | $78.56 M(-11.5%) |
| Sept 2021 | - | $88.72 M(-35.4%) |
| June 2021 | - | $137.42 M(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $153.06 M(+95.9%) | $153.06 M(+207.6%) |
| June 2020 | - | $49.75 M(-36.3%) |
| Dec 2019 | $78.14 M(-22.3%) | $78.14 M(+12.9%) |
| June 2019 | - | $69.23 M(-31.1%) |
| Dec 2018 | $100.51 M(-25.4%) | $100.51 M(+8.2%) |
| June 2018 | - | $92.88 M(-31.1%) |
| Dec 2017 | $134.81 M(-8.4%) | $134.81 M(+8.7%) |
| June 2017 | - | $124.07 M(-15.7%) |
| Dec 2016 | $147.15 M(-25.6%) | $147.15 M(-18.4%) |
| June 2016 | - | $180.44 M(-8.7%) |
| Dec 2015 | $197.66 M(+3.8%) | $197.66 M(+4.2%) |
| June 2015 | - | $189.61 M(-0.5%) |
| Dec 2014 | $190.51 M(+75.9%) | $190.51 M |
| Dec 2013 | $108.32 M | - |
FAQ
- What is Molecular Partners AG annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Molecular Partners AG?
- What is Molecular Partners AG annual cash & cash equivalents year-on-year change?
- What is Molecular Partners AG quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Molecular Partners AG?
- What is Molecular Partners AG quarterly cash and cash equivalents year-on-year change?
What is Molecular Partners AG annual cash & cash equivalents?
The current annual cash & cash equivalents of MOLN is $80.14 M
What is the all time high annual cash & cash equivalents for Molecular Partners AG?
Molecular Partners AG all-time high annual cash & cash equivalents is $197.66 M
What is Molecular Partners AG annual cash & cash equivalents year-on-year change?
Over the past year, MOLN annual cash & cash equivalents has changed by -$14.72 M (-15.52%)
What is Molecular Partners AG quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MOLN is $78.16 M
What is the all time high quarterly cash and cash equivalents for Molecular Partners AG?
Molecular Partners AG all-time high quarterly cash and cash equivalents is $197.66 M
What is Molecular Partners AG quarterly cash and cash equivalents year-on-year change?
Over the past year, MOLN quarterly cash and cash equivalents has changed by +$3.40 M (+4.55%)